BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22847990)

  • 21. The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas.
    Palmerini E; Colangeli M; Nanni C; Fanti S; Marchesi E; Paioli A; Picci P; Cambioli S; Donati D; Cevolani L; De Paolis M; Gambarotti M; Ferrari S
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):215-223. PubMed ID: 27645694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence of neural differentiation in a case of post-therapy primitive neuroectodermal tumor/Ewing sarcoma of bone.
    Collini P; Mezzelani A; Modena P; Dagrada P; Tamborini E; Luksch R; Gronchi A; Navarria P; Sozzi G; Pilotti S
    Am J Surg Pathol; 2003 Aug; 27(8):1161-6. PubMed ID: 12883251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features and outcomes of infants with Ewing sarcoma under 12 months of age.
    Wong T; Goldsby RE; Wustrack R; Cash T; Isakoff MS; DuBois SG
    Pediatr Blood Cancer; 2015 Nov; 62(11):1947-51. PubMed ID: 26173989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of locus of care on outcomes in adolescents and young adults with osteosarcoma and Ewing sarcoma treated at pediatric versus adult cancer centers: An IMPACT cohort study.
    Mortazavi M; Baxter NN; Gupta S; Gupta AA; Lau C; Nagamuthu C; Nathan PC
    Pediatr Blood Cancer; 2022 Apr; 69(4):e29458. PubMed ID: 35029312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-708-5p is inversely associated with EWS/FLI1 Ewing sarcoma but does not represent a prognostic predictor.
    Roberto GM; Vieira GM; Delsin LEA; Silva MO; Hakime RG; Engel EE; Scrideli CA; Tone LG; Brassesco MS
    Cancer Genet; 2019 Jan; 230():21-27. PubMed ID: 30470587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second malignancy in 597 patients with ewing sarcoma of bone treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999.
    Bacci G; Longhi A; Barbieri E; Ferrari S; Mercuri M; Briccoli A; Versari M; Pignotti E; Picci P
    J Pediatr Hematol Oncol; 2005 Oct; 27(10):517-20. PubMed ID: 16217253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival outcomes in pediatric patients with metastatic Ewing sarcoma who achieve a rapid complete response of pulmonary metastases.
    Reiter AJ; Huang L; Craig BT; Davidoff AM; Talbot LJ; Coggins J; Smith J; Aldrink JH; Bergus KC; MacArthur TA; Polites SF; Boehmer C; Brungardt J; Malek MM; Rinehardt HN; Kastenberg ZJ; Arkin CM; Gourmel A; Piche N; Wallace M; Liang J; Lovvorn HN; Petroze RT; Gillies G; Marquart JP; Becktell K; Le HD; Favela J; Rich BS; Glick RD; Seemann NM; Davidson J; Wilson CA; Roach J; Brown EG; Doyle KE; Coakley BA; Emengo P; Merola P; Grant CN; Tirumani A; Tracy ET; Moya-Mendez ME; Dasgupta R; Lautz TB;
    Pediatr Blood Cancer; 2024 Jul; 71(7):e31026. PubMed ID: 38679864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group.
    van Doorninck JA; Ji L; Schaub B; Shimada H; Wing MR; Krailo MD; Lessnick SL; Marina N; Triche TJ; Sposto R; Womer RB; Lawlor ER
    J Clin Oncol; 2010 Apr; 28(12):1989-94. PubMed ID: 20308669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and pathological features of primary neuroectodermal tumor/Ewing sarcoma of the kidney.
    Risi E; Iacovelli R; Altavilla A; Alesini D; Palazzo A; Mosillo C; Trenta P; Cortesi E
    Urology; 2013 Aug; 82(2):382-6. PubMed ID: 23800653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of local treatment strategies in non-metastatic Ewing sarcoma of bone.
    Zhang WT; Zhang WW; He ZY; Sun JY; Zhang L; Xia Q; Wu SG
    Expert Rev Anticancer Ther; 2018 May; 18(5):501-506. PubMed ID: 29537323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the Interdisciplinary Tumor Board of the Cooperative Ewing Sarcoma Study Group on local therapy and overall survival of Ewing sarcoma patients after induction therapy.
    Kreyer J; Ranft A; Timmermann B; Juergens H; Jung S; Wiebe K; Boelling T; Schuck A; Vieth V; Streitbuerger A; Hardes J; Heinemann M; Dirksen U
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27384. PubMed ID: 30084137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of recurrence and survival after relapse in patients with Ewing sarcoma.
    Stahl M; Ranft A; Paulussen M; Bölling T; Vieth V; Bielack S; Görtitz I; Braun-Munzinger G; Hardes J; Jürgens H; Dirksen U
    Pediatr Blood Cancer; 2011 Oct; 57(4):549-53. PubMed ID: 21442722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Timing of Local Therapy Affects Survival in Ewing Sarcoma.
    Lin TA; Ludmir EB; Liao KP; McAleer MF; Grosshans DR; McGovern SL; Bishop AJ; Woodhouse KD; Paulino AC; Yeboa DN
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):127-136. PubMed ID: 30593906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Whole Lung Irradiation on Survival Outcome in Patients With Lung Relapsed Ewing Sarcoma.
    Scobioala S; Ranft A; Wolters H; Jabar S; Paulussen M; Timmermann B; Juergens H; Hassenpflug W; Klingebiel T; Elsayad K; Eich HT; Dirksen U
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):584-592. PubMed ID: 30244879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary cutaneous Ewing sarcoma: a systematic review focused on treatment and outcome.
    Delaplace M; Lhommet C; de Pinieux G; Vergier B; de Muret A; Machet L
    Br J Dermatol; 2012 Apr; 166(4):721-6. PubMed ID: 22098102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Survival of pediatric patients with Ewing sarcoma treated at Semmelweis University].
    Geiszl Z; Kiss J; Szendrõi M; Vízkeleti J; Arató G; Sápi Z; Kriván G; Mohás A; Rényi I; Garami M; Hauser P
    Magy Onkol; 2018 Dec; 62(4):230-236. PubMed ID: 30540865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive radiotherapy for pediatric Ewing Sarcoma: Outcomes of a prospective proton study.
    Bronk JK; McAleer MF; McGovern SL; Lassen-Ramshad Y; Safwat A; Daw NC; Rainusso N; Mahajan A; Grosshans DR; Paulino AC
    Radiother Oncol; 2024 Jun; 195():110270. PubMed ID: 38583721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.
    He T; Surdez D; Rantala JK; Haapa-Paananen S; Ban J; Kauer M; Tomazou E; Fey V; Alonso J; Kovar H; Delattre O; Iljin K
    Gene; 2017 Jan; 596():137-146. PubMed ID: 27760381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pelvis Ewing sarcoma: Local control and survival in the modern era.
    Ahmed SK; Robinson SI; Arndt CAS; Petersen IA; Haddock MG; Rose PS; Issa Laack NN
    Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28244685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of detectable EWS/FLI1 expression after therapy-induced neural differentiation in Ewing sarcoma.
    Knezevich SR; Hendson G; Mathers JA; Carpenter B; Lopez-Terrada D; Brown KL; Sorensen PH
    Hum Pathol; 1998 Mar; 29(3):289-94. PubMed ID: 9496833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.